A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Number of shares, 3 months chart
Year | Volume (Price x Shares) | Change |
---|---|---|
2025 | NZ$0.58 M | -82.25% |
2024 | NZ$3.28 M | -6.99% |
2023 | NZ$3.53 M | -45.13% |
2022 | NZ$6.43 M | -51.16% |
2021 | NZ$13.17 M | -41.25% |
2020 | NZ$22.43 M | 52.77% |
2019 | NZ$14.68 M | 6.59% |
2018 | NZ$13.77 M | 361.3% |
2017 | NZ$2.98 M | -15.54% |
2016 | NZ$3.53 M | -61.86% |
2015 | NZ$9.27 M | 147.12% |
2014 | NZ$3.75 M | 2529.01% |
2013 | NZ$0.14 M |
Company | FTD volume (3 months) | FTD volume (1 year) | Country |
---|---|---|---|
![]() Seagen
SGEN | N/A | NZ$3.02 M | ๐บ๐ธ USA |
![]() MacroGenics MGNX | NZ$0.02 M | NZ$1.99 M | ๐บ๐ธ USA |
![]() Amgen AMGN | NZ$82.72 M | NZ$0.33 B | ๐บ๐ธ USA |
![]() Merck MRK | NZ$19.34 M | NZ$0.18 B | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | NZ$8.74 M | NZ$0.19 B | ๐บ๐ธ USA |
![]() AbbVie ABBV | NZ$33.49 M | NZ$0.23 B | ๐บ๐ธ USA |